Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. It is not yet known which combination chemotherapy regimen is more
effective for multiple myeloma.
PURPOSE: This randomized phase III trial is comparing two combination chemotherapy regimens
to see how well they work in treating patients with stage II or stage III multiple myeloma.